Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on: February 18,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on:February 18,2024

Researchers share insights on the evolution of proton radiotherapy

by Mass General BrighamCredit: Unsplash/CC0 Public DomainIn a review article published inThe Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MG

Updated on: February 01,2024

Researchers share insights on the evolution of proton radiotherapy

by Mass General BrighamCredit: Unsplash/CC0 Public DomainIn a review article published inThe Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MG

Updated on:February 01,2024

A novel strategy to suppress triple negative breast cancer growth

by Homa Shalchi,Baylor College of MedicineCredit:PLOS Biology(2023). DOI: 10.1371/journal.pbio.3002227In 2022, a team of researchers at Baylor College of Medicinediscovered&nbs

Updated on: February 01,2024

A novel strategy to suppress triple negative breast cancer growth

by Homa Shalchi,Baylor College of MedicineCredit:PLOS Biology(2023). DOI: 10.1371/journal.pbio.3002227In 2022, a team of researchers at Baylor College of Medicinediscovered&nbs

Updated on:February 01,2024

New study brings personalized immunotherapy prescriptions a step closer

byUniversity of BathCredit: Unsplash/CC0 Public DomainIn a step likely to advance personalized cancer treatment, scientists have—for the first time—shown in patients that levels of biomarkers ar

Updated on: January 13,2024

New study brings personalized immunotherapy prescriptions a step closer

byUniversity of BathCredit: Unsplash/CC0 Public DomainIn a step likely to advance personalized cancer treatment, scientists have—for the first time—shown in patients that levels of biomarkers ar

Updated on:January 13,2024

Resetting the epigenetic balance for cancer therapy

by Will Doss,Northwestern UniversityKiller T cells surround a cancer cell. Credit: NIHThough mutations in a gene called MLL3 are common across many types of cancers, their relationship to the de

Updated on: April 07,2024

Resetting the epigenetic balance for cancer therapy

by Will Doss,Northwestern UniversityKiller T cells surround a cancer cell. Credit: NIHThough mutations in a gene called MLL3 are common across many types of cancers, their relationship to the de

Updated on:April 07,2024

Researchers accurately predict how well body will fight lung cancer based on patterns of immune cells

by Case Western Reserve UniversityActual photographs of the shape of the cancer-associated immune cells. Credit: Case Western Reserve UniversityResearchers at Case Western Reserve University have

Updated on: March 01,2024

Researchers accurately predict how well body will fight lung cancer based on patterns of immune cells

by Case Western Reserve UniversityActual photographs of the shape of the cancer-associated immune cells. Credit: Case Western Reserve UniversityResearchers at Case Western Reserve University have

Updated on:March 01,2024

Study: Mitochondria engage the integrated stress response to promote tumor growth

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper, titled "Mitochondria engage the integrated stress response to promote tumor growth," was published inOncot

Updated on: January 30,2024

Study: Mitochondria engage the integrated stress response to promote tumor growth

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper, titled "Mitochondria engage the integrated stress response to promote tumor growth," was published inOncot

Updated on:January 30,2024

New biomarker strategy devised to screen for, diagnose deadly heart complication from cancer treatment

byUniversity of MichiganCredit: Unsplash/CC0 Public DomainResearchers at Michigan Medicine have devised a new biomarker-based strategy to screen for a rare and deadly complication caused by mono

Updated on: January 12,2024

New biomarker strategy devised to screen for, diagnose deadly heart complication from cancer treatment

byUniversity of MichiganCredit: Unsplash/CC0 Public DomainResearchers at Michigan Medicine have devised a new biomarker-based strategy to screen for a rare and deadly complication caused by mono

Updated on:January 12,2024

Investigators reveal changes to immune status in patient tumors after radiation

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainLittle is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors

Updated on: January 30,2024

Investigators reveal changes to immune status in patient tumors after radiation

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainLittle is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors

Updated on:January 30,2024

Long-term survey reveals worsening death rate for oral cancer in Queensland

by James Cook UniversityTrends in number of cases and number of deaths during the 36-year period. Credit:Journal of Oral Pathology & Medicine(2023). DOI: 10.1111/jop.13421A study

Updated on: January 30,2024

Long-term survey reveals worsening death rate for oral cancer in Queensland

by James Cook UniversityTrends in number of cases and number of deaths during the 36-year period. Credit:Journal of Oral Pathology & Medicine(2023). DOI: 10.1111/jop.13421A study

Updated on:January 30,2024

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Updated on: February 03,2024

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Updated on:February 03,2024

Common diabetes drug slows growth of normal cells carrying cancer mutation, finds study

byWellcome Trust Sanger InstitutePIK3CA mutant clones in human esophageal epithelium. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01891-8A common diabetes medication, metfo

Updated on: September 28,2024

Common diabetes drug slows growth of normal cells carrying cancer mutation, finds study

byWellcome Trust Sanger InstitutePIK3CA mutant clones in human esophageal epithelium. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01891-8A common diabetes medication, metfo

Updated on:September 28,2024